Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sulfatase 1 (SULF1) is an extracellular enzyme belonging to the arylsulfatase family that regulates cell signaling by specifically removing 6-O-sulfate groups from heparan sulfate (HS) chains on proteoglycans found on the cell surface and in the extracellular matrix. This desulfation modifies the ability of HS to bind growth factors and cytokines (such as Wnt, BMP, FGF, VEGF, and others), thus fine-tuning signaling pathways involved in cell proliferation, differentiation, migration, and developmental patterning. SULF1 activity also impacts signaling in pathological processes such as cancer and osteoarthritis, where altered SULF1 expression can affect disease progression. SULF1 is structurally related to other arylsulfatases but is unique in its extracellular activity and specificity for heparan sulfate 6-O-desulfation.
Enzymatic removal of 6-O-sulfate groups from heparan sulfate chains on proteoglycans, altering growth factor and cytokine binding and downstream signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulfatase 1 (SULF1).